Screener
Allogene Therapeutics ALLO Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Allogene Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
FAQ
- What is Allogene Therapeutics's operating margin?
- Allogene Therapeutics (ALLO) reported operating margin of -1,241,813.6% in Q4 2024.
- How has Allogene Therapeutics's operating margin changed year-over-year?
- Allogene Therapeutics's operating margin decreased by 260.0% year-over-year, from -344,986.3% to -1,241,813.6%.
- What is the long-term trend for Allogene Therapeutics's operating margin?
- Over 3 years (2021 to 2024), Allogene Therapeutics's operating margin has grown at a 1882.2% compound annual growth rate (CAGR), from -159.4% to -1,241,813.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Allogene Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude